Characterization of a Bcl-X L-interacting protein FKBP8 and its splice variant in human RPE cells

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 4, 2008, Pages 1721-1727

  Chen, Yan ^a   Sternberg, Paul ^a   Cai, Jiyang ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOPHILIN; PROTEIN BCL XL; PROTEIN FKBP8; RNA; TERT BUTYL HYDROPEROXIDE; THAPSIGARGIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; BCL2L1 PROTEIN, HUMAN; FK 506 BINDING PROTEIN; FKBP8 PROTEIN, HUMAN; ISOPROTEIN; MESSENGER RNA; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GENE AMPLIFICATION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BCL-X PROTEIN; CELLS, CULTURED; EXONS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, CONFOCAL; NFATC TRANSCRIPTION FACTORS; PIGMENT EPITHELIUM OF EYE; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS BINDING PROTEINS; TERT-BUTYLHYDROPEROXIDE; THAPSIGARGIN; TRANSFECTION;

EID: 45549106458     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1121     Document Type: Article

References (48)

1. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
2. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552-577.
3. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120: 1435-1442.
4. Hinton DR, He S, Lopez PF. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol. 1998;116:203-209.
5. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Ven- katachalam MA. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med. 1999;107:489-506.
6. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (review). Int J Oncol. 2003;22:15-20.
7. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol. 2007;47:143-183.
8. Chan SL, Yu VC. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol. 2004;31:119-128.
9. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to heart. Am JPhysiol. 2007;292:C45-C51.
10. Zhang N, Peairs JJ, Yang P, et al. The importance of Bcl-xL in the survival of human RPE cells. Invest Ophthalmol Vis Sci. 2007;48: 3846-3853.
11. Shirane M, Nakayama KI. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol. 2003;5:28-37.
12. Wang HQ, Nakaya Y, Du Z, et al. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2. Hum Mol Genet. 2005;14:1889-1902.
13. Edlich F, Weiwad M, Erdmann F, et al. Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin. EMBO J. 2005;24:2688-2699.
14. Kang CB, Feng L, Chia J, Yoon HS. Molecular characterization of FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic protein Bcl-2. Biochem Biophys Res Commun. 2005;337:30-38.
15. Harrar Y, Bellini C, Faure JD. FKBPs: at the crossroads of folding and transduction. Trends Plant Sci. 2001;6:426-431.
16. Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000;7:731-748.
17. Barik S. Immunophilins: for the love of proteins. Cell Mol Life Sci. 2006;63:2889-2900.
18. Timerman AP, Ogunbumni E, Freund E, Wiederrecht G, Marks AR, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein: dissociation and reconsti- tution ofFKBP-12 to the calcium release channel ofskeletal muscle sarcoplasmic reticulum. JBiol Chem. 1993;268:22992-22999.
19. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci USA. 1995;92:1784-1788.
20. Shou W, Aghdasi B, Armstrong DL, et al. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 1998;391:489- 492.
21. Lam E, Martin M, Wiederrecht G. Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs. Gene. 1995;160:297- 302.
22. Nielsen JV, Mitchelmore C, Pedersen KM, Kjaerulff KM, Finsen B, Jensen NA. Fkbp8: novel isoforms, genomic organization, and characterization of a forebrain promoter in transgenic mice. Genomics. 2004;83:181-192.
23. Weiwad M, Edlich F, Erdmann F, et al. A reassessment of the inhibitory capacity of human FKBP38 on calcineurin. FEBS Lett. 2005;579:1591-1596.
24. Bulgakov OV, Eggenschwiler JT, Hong DH, Anderson KV, Li T. FKBP8 is a negative regulator of mouse sonic hedgehog signaling in neural tissues. Development. 2004;131:2149-2159.
25. Jiang S, Wu MW, Sternberg P, Jones DP. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Invest Ophthalmol Vis Sci. 2000;41:645-655.
26. Cai J, Kirlin WG, Chen Y, Yan X, Jones DP, Sartorelli AC. Overex- pression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells. Cell Stress Chaperones. 2006;11:199 - 207.
27. Jiang S, Cai J, Wallace DC, Jones DP. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA: signaling pathway involving release and caspase 3 activation is conserved. J Biol Chem. 1999;274:29905-29911.
28. Chen Y, Cai J, Murphy TJ, Jones DP. Overexpressed human mito- chondrial thioredoxin confers resistance to oxidant-induced apo- ptosis in human osteosarcoma cells. J Biol Chem. 2002;277: 33242-33248.
29. Ha KN, Chen Y, Cai J, Sternberg P Jr. Increased glutathione synthesis through an ARE-Nrf2-dependent pathway by zinc in the RPE: implication for protection against oxidative stress. Invest Ophthal-mol Vis Sci. 2006;47:2709-2715.
30. Okamoto T, Nishimura Y, Ichimura T, et al. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J. 2006;25: 5015-5025.
31. Moshfeghi DM, Blumenkranz MS. Role of genetic factors and inflammation in age-related macular degeneration. Retina. 2007;27: 269-275.
32. DeWan A, Bracken MB, Hoh J. Two genetic pathways for age- related macular degeneration. Curr Opin Genet Dev. 2007;17: 228-233.
33. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51:137-152.
34. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
35. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch,s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
36. Yildirim O, Ates NA, Tamer L, et al. Changes in antioxidant enzyme activity and malondialdehyde level in patients with age-related macular degeneration. Ophthalmologica. 2004;218:202-206.
37. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19: 205-221.
38. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
39. AREDS study group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-1452.
40. Reed JC. Bcl-2 family proteins. Oncogene. 1998;17:3225-3236.
41. Kang CB, Tai J, Chia J, Yoon HS. The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK- 506 binding protein 38 (FKBP38). FEBS Lett. 2005;579:1469-1476.
42. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic re- ticulum, and outer mitochondrial membranes. Cancer Res. 1993; 53:4701-4714.
43. Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y. Multiple subcel- lular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 1994;54:2468-2471.
44. Li C, Wang X, Vais H, Thompson CB, Foskett JK, White C. Apo-ptosis regulation by Bcl-x(L) modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating. Proc Natl Acad Sci USA. 2007;104:12565-12570.
45. Xu L, Kong D, Zhu L, Zhu W, Andrews DW, Kuo TH. Suppression of IP3-mediated calcium release and apoptosis by Bcl-2 involves the participation of protein phosphatase 1. Mol Cell Biochem. 2007;295:153-165.
46. Pinton P, Rizzuto R. Bcl-2 and Ca2+ homeostasis in the endoplas-mic reticulum. Cell Death Differ. 2006;13:1409 -1418.
47. Hoyer-Hansen M, Bastholm L, Szyniarowski P, et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase- beta, and Bcl-2. Mol Cell. 2007;25:193-205.
48. Gold BG, Nutt JG. Neuroimmunophilin ligands in the treatment of Parkinson,s disease. Curr Opin Pharmacol. 2002;2:82- 86.